{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T01:18:49Z","timestamp":1790644729132,"version":"4.1.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2008,8,10]],"date-time":"2008-08-10T00:00:00Z","timestamp":1218326400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1007\/s00213-008-1260-2","type":"journal-article","created":{"date-parts":[[2008,8,9]],"date-time":"2008-08-09T03:59:54Z","timestamp":1218254394000},"page":"171-181","source":"Crossref","is-referenced-by-count":75,"title":["Delta-9-tetrahydrocannabinol (THC) serum concentrations and pharmacological effects in males after smoking a combination of tobacco and cannabis containing up to 69\u00a0mg THC"],"prefix":"10.1007","volume":"201","author":[{"given":"Claudine C.","family":"Hunault","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tjeert T.","family":"Mensinga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irma","family":"de Vries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hermien H.","family":"Kelholt-Dijkman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jani","family":"Hoek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maaike","family":"Kruidenier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne E. C.","family":"Leenders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Meulenbelt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,8,10]]},"reference":[{"key":"1260_CR1","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0031-6997(25)06861-9","volume":"38","author":"S Agurell","year":"1986","unstructured":"Agurell S, Halldin M, Lindgren JE, Ohlsson A, Widman M, Gillepsie H, Hollister L (1986) Pharmacokinetics and metabolism of delta 1-tetrahydrocannabinol and other cannabinoids with emphasis on man. Pharmacol Rev 38:21\u201343","journal-title":"Pharmacol Rev"},{"key":"1260_CR2","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/PL00000897","volume":"58","author":"P Anzenbacher","year":"2001","unstructured":"Anzenbacher P, Anzenbacherov\u00e1 E (2001) Cytochromes P450 and metabolism of xenobiotics. Cell Mol Life Sci 58:737\u2013747","journal-title":"Cell Mol Life Sci"},{"key":"1260_CR3","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/BF01059033","volume":"10","author":"G Barnett","year":"1982","unstructured":"Barnett G, Chiang CW, Perez-Reyes M, Owens SM (1982) Kinetic study of smoking marijuana. J Pharmacokinet Biopharm 10:495\u2013506","journal-title":"J Pharmacokinet Biopharm"},{"key":"1260_CR4","first-page":"241","volume":"20","author":"LM Bornheim","year":"1992","unstructured":"Bornheim LM, Lasker JM, Raucy JL (1992) Human hepatic microsomal metabolism of \u03941-tetrahydrocannabinol. Drug Metab Depos 20:241\u2013246","journal-title":"Drug Metab Depos"},{"key":"1260_CR5","volume-title":"Quarterly report potency monitoring project #85","author":"MA Sohly El","year":"2004","unstructured":"El Sohly MA (2004) Quarterly report potency monitoring project #85. National Center for Natural Products Research, University of Mississippi, Oxford, USA"},{"key":"1260_CR6","unstructured":"EMCDDA (2007) Annual report from the EU drugs agency: the state of the drugs problem in Europe. Available at http:\/\/www.emcdda.europa.eu\/html.cfm\/index419EN.html"},{"key":"1260_CR7","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0091-3057(97)00386-9","volume":"60","author":"RV Fant","year":"1998","unstructured":"Fant RV, Heishman SJ, Bunker EB, Pickworth WB (1998) Acute and residual effects of marijuana in humans. Pharmacol Biochem Behav 60:777\u2013784","journal-title":"Pharmacol Biochem Behav"},{"key":"1260_CR8","doi-asserted-by":"crossref","first-page":"327","DOI":"10.2165\/00003088-200342040-00003","volume":"42","author":"F Grothenhermen","year":"2003","unstructured":"Grothenhermen F (2003) Pharmacokinetics and pharmacodynamics of cannabinoids. Clin Pharmacokinet 42:327\u2013360","journal-title":"Clin Pharmacokinet"},{"key":"1260_CR9","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jchromb.2003.09.022","volume":"798","author":"RA Gustafson","year":"2003","unstructured":"Gustafson RA, Moolchan ET, Barnes A, Levine B, Huestis MA (2003) Validated method for the simultaneous determination of Delta 9-tetrahydrocannabinol (THC), 11-hydroxy-THC and 11-nor-9-carboxy-THC in human plasma using solid phase extraction and gas chromatography-mass spectrometry with positive chemical ionization. J Chromatogr B Analyt Technol Biomed Life Sci 798:145\u2013154","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"1260_CR10","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S0893-133X(01)00273-1","volume":"25","author":"CL Hart","year":"2001","unstructured":"Hart CL, van Gorp W, Haney M, Foltin RW, Fischman MW (2001) Effects of acute smoked marijuana on complex cognitive performance. Neuropsychopharmacology 25:757\u2013765","journal-title":"Neuropsychopharmacology"},{"key":"1260_CR11","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/clpt.1992.100","volume":"52","author":"MA Huestis","year":"1992","unstructured":"Huestis MA, Sampson AH, Holicky BJ, Henningfield JE, Cone EJ (1992a) Characterization of the absorption phase of marijuana smoking. Clin Pharmacol Ther 52:31\u201341","journal-title":"Clin Pharmacol Ther"},{"key":"1260_CR12","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1093\/jat\/16.5.276","volume":"16","author":"MA Huestis","year":"1992","unstructured":"Huestis MA, Henningfield JE, Cone EJ (1992b) Blood cannabinoids. I. Absorption of THC and formation of 11-OH-THC and THCCOOH during and after smoking marijuana. J Anal Toxicol 16:276\u2013282","journal-title":"J Anal Toxicol"},{"key":"1260_CR13","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1093\/jat\/16.5.283","volume":"16","author":"MA Huestis","year":"1992","unstructured":"Huestis MA, Henningfield JE, Cone EJ (1992c) Blood cannabinoids. II. Models for the prediction of time of marijuana exposure from plasma concentrations of delta 9-tetrahydrocannabinol (THC) and 11-nor-9-carboxy-delta 9-tetrahydrocannabinol (THCCOOH). J Anal Toxicol 16:283\u2013290","journal-title":"J Anal Toxicol"},{"key":"1260_CR14","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/(SICI)1099-0801(199711)11:6<371::AID-BMC685>3.0.CO;2-Y","volume":"11","author":"P Kintz","year":"1997","unstructured":"Kintz P, Cirimele V (1997) Testing human blood for cannabis by GC-MS. Biomed Chromatogr 11:371\u2013373","journal-title":"Biomed Chromatogr"},{"key":"1260_CR15","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1038\/sj.npp.1300620","volume":"30","author":"SD Lane","year":"2005","unstructured":"Lane SD, Cherek DR, Tcheremssine OV, Lieving LM, Pietras CJ (2005) Acute marijuana effects on human risk taking. Neuropsychopharmacology 30:800\u2013809","journal-title":"Neuropsychopharmacology"},{"key":"1260_CR16","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1007\/BF00427095","volume":"74","author":"JE Lindgren","year":"1981","unstructured":"Lindgren JE, Ohlsson A, Agurell S, Hollister L, Gillepsie H (1981) Clinical effects and plasma levels of delta 9-tetrahydrocannabinol (delta 9-THC) in heavy and light users of cannabis. Psychopharmacology 74:208\u2013212","journal-title":"Psychopharmacology"},{"key":"1260_CR17","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1002\/jms.616","volume":"39","author":"B Maralikova","year":"2004","unstructured":"Maralikova B, Weinmann W (2004) Simultaneous determination of Delta9-tetrahydrocannabinol, 11-hydroxy-Delta9-tetrahydrocannabinol and 11-nor-9-carboxy-Delta9-tetrahydrocannabinol in human plasma by high-performance liquid chromatography\/tandem mass spectrometry. J Mass Spectrom 39:526\u2013531","journal-title":"J Mass Spectrom"},{"key":"1260_CR18","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1520\/JFS13282J","volume":"37","author":"MR Moeller","year":"1992","unstructured":"Moeller MR, Doerr G, Warth S (1992) Simultaneous quantitation of delta-9-tetrahydrocannabinol (THC) and 11-nor-9-carboxy-delta-9-tetrahydrocannabinol (THC-COOH) in serum by GC\/MS using deuterated internal standards and its application to a smoking study and forensic cases. J Forensic Sci 37:969\u2013983","journal-title":"J Forensic Sci"},{"key":"1260_CR19","volume-title":"THC-concentraties in wiet, nederwiet en hasj in Nederlandse coffeeshops (2006\u20132007)","author":"RJM Niesink","year":"2007","unstructured":"Niesink RJM, Rigter S, Hoek J, Goldschmidt H (2007) THC-concentraties in wiet, nederwiet en hasj in Nederlandse coffeeshops (2006\u20132007). Trimbos Instituut, Utrecht, The Netherlands"},{"key":"1260_CR20","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/bms.1200090103","volume":"9","author":"A Ohlsson","year":"1982","unstructured":"Ohlsson A, Lindgren JE, Wahl\u00e9n A, Agurell S, Hollister LE, Gillepsie HK (1982) Single dose kinetics of deuterium labelled delta 1-tetrahydrocannabinol in heavy and light cannabis users. Biomed Mass Spectrom 9:6\u201310","journal-title":"Biomed Mass Spectrom"},{"key":"1260_CR21","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/clpt.1982.86","volume":"31","author":"M Perez-Reyes","year":"1982","unstructured":"Perez-Reyes M, Di Guiseppi S, Davis K, Schindler VH, Cook CE (1982) Comparison of effects of marihuana cigarettes of three different potencies. Clin Pharmacol Ther 31:617\u2013624","journal-title":"Clin Pharmacol Ther"},{"key":"1260_CR22","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1038\/sj.npp.1301068","volume":"31","author":"JG Ramaekers","year":"2006","unstructured":"Ramaekers JG, Kauert G, van Ruitenbeek P, Theunissen EL, Schneider E, Moeller MR (2006) High-potency marijuana impairs executive function and inhibitory motor control. Neuropsychopharmacology 31:2296\u20132303","journal-title":"Neuropsychopharmacology"},{"key":"1260_CR23","first-page":"514","volume":"31","author":"P Tanswell","year":"1993","unstructured":"Tanswell P, Koup J (1993) TopFit: a PC-based pharmacokinetic-pharmacodynamic data analysis program. Int J Clin Pharm Ther Toxicol 31:514\u2013520","journal-title":"Int J Clin Pharm Ther Toxicol"},{"key":"1260_CR24","first-page":"624","volume":"255","author":"BF Thomas","year":"1990","unstructured":"Thomas BF, Compton DR, Martin BR (1990) Characteristization of the lipophility of natural and synthetic analogs of delta 9-tetrahydrocannabinol and its relationship to pharmacological potency. J Anal Toxicol 255:624\u2013630","journal-title":"J Anal Toxicol"},{"key":"1260_CR25","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/sj.bjp.0704479","volume":"135","author":"E Valjent","year":"2002","unstructured":"Valjent E, Mitchell JM, Besson MJ, Caboche J, Maldonado R (2002) Behavioural and biochemical evidence for interactions between Delta 9-tetrahydrocannabinol and nicotine. Br J Pharmacol 135:564\u2013578","journal-title":"Br J Pharmacol"},{"key":"1260_CR26","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/j.lfs.2006.12.032","volume":"80","author":"K Watanabe","year":"2007","unstructured":"Watanabe K, Yamaori S, Funahashi T, Kimura T, Yamamoto I (2007) Cytochrome P450 enzymes involved in the metabolism of tetrahydrocannabinols and cannabinol by human hepatic microsomes. Life Sci 80:1415\u20131419","journal-title":"Life Sci"},{"key":"1260_CR27","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1111\/j.2042-7158.1974.tb09207.x","volume":"26","author":"M Widman","year":"1974","unstructured":"Widman M, Agurell S, Ehrnebo M, Jones G (1974) Binding of (+)- and (\u2212)-D1-tetracannabinols and (\u2212)-7-hydroxy-\u03941-tetracannabinol to blood cells and plasma proteins in man. J Pharm Pharmacol 26:914\u2013916","journal-title":"J Pharm Pharmacol"},{"key":"1260_CR28","unstructured":"World Drug Report (2006) Volume 1 (analysis). United Nations Office on Drugs and Crime, United Nations Publication Sales No. E.06.XI.10"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-008-1260-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-008-1260-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-008-1260-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T06:14:48Z","timestamp":1738304088000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-008-1260-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8,10]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["1260"],"URL":"https:\/\/doi.org\/10.1007\/s00213-008-1260-2","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,8,10]]}}}